, a former graduate student in Doudna’s lab who did some of the foundational work on CRISPR.
“It does a far better job of making the changes you want, avoiding others and allowing multiple edits because the specificity is better to empower anti-cancer activity,” Haurwitz said.How differently the Caribou team looks from the makeup of the rest of the industry. There are few publicly traded companies that have more women than men on the board. Our leadership is half women, and there are more women across the company.
As the company pivoted from one that licensed out its technology to a therapy-development company, how did you handle that internally? The credit goes to so many people. You don’t succeed on something like this when the CEO is just pounding on the table saying, “This is a priority.”No. The inclusion team really built itself. They supported routine surveys to check in on culture and helped HR on strategies to target potential new talent. Success comes when people invest in this.The cofounders were all excited by the potential — all of us. The biggest thing I underestimated was how challenging some or most of this work could be.